Ultra Market Research | Global Arterial Cannula Market
Global Arterial Cannula Market
Report ID : 914
Category : Medical-Devices
No Of Pages : 90
Published on: December 2024
Status: Published
Format :
Key Question Answer
Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major players financial performance.
Evaluate strategies adopted by major players.
Recommendations
Global Arterial Cannula Market
Introduction
The Global Arterial Cannula Market represents the industry focused on designing, manufacturing, and selling arterial cannulas, which are used to maintain blood flow in cardiovascular surgery and extracorporeal circulation. The cannulas play a critical role in ensuring that blood flow remains stable during such critical surgeries as heart bypass and other cardiovascular interventions. The use is extended to hospitals, specialty clinics, and ambulatory surgical centers. The current trends comprise of more advanced cannula materials; increased biocompatibility levels, and an integration with anti-thrombogenic coatings for patients' comfort. The industry has, however been marked by consecutive growth with cardiovascular diseases diagnosed in people more regularly, not to mention demand for these procedures to increase minimally invasive procedures. By the year 2024, the market will have already grown to $1.2 billion from an initial size and growth rate estimate of 5.8% CAGR in a five-year duration.
Segmentation
Product Type
Straight Arterial Cannulas
Pediatric Cannulas
Adult Cannulas
Others
Curved Arterial Cannulas
Pediatric Cannulas
Adult Cannulas
Dual-Stage Arterial Cannulas
Pediatric Cannulas
Adult Cannulas
Material
Polymer-Based Cannulas
Silicone
Polyurethane
Others
Metal-Based Cannulas
Stainless Steel
Titanium
Hybrid Materiala Application
Cardiac Surgery
Coronary Artery Bypass Grafting (CABG)
Valve Replacement Surgery
Others
Extracorporeal Membrane Oxygenation (ECMO)
Neonatal ECMO
Adult ECMO
Other Surgeries
End User
Hospitals
Public Hospitals
Private Hospitals
Ambulatory Surgical Centers
Specialty Clinics
List of Market Players
Medtronic (USA)
Terumo Corporation (Japan)
Edwards Lifesciences Corporation (USA)
LivaNova PLC (UK)
Getinge Group (Sweden)
B. Braun Melsungen AG (Germany)
Boston Scientific Corporation (USA)
Teleflex Incorporated (USA)
W.L. Gore & Associates (USA)
Abbott Laboratories (USA)
Smiths Medical (UK)
BD (Becton, Dickinson and Company) (USA)
Nipro Corporation (Japan)
Fresenius Medical Care AG & Co. KGaA (Germany)
Artivion, Inc. (USA)
Drivers
The main drivers for the Global Arterial Cannula Market are the increasing prevalence of cardiovascular diseases across the world and the rising geriatric population, which is more susceptible to such conditions. Moreover, improvements in healthcare infrastructure and the increased adoption of minimally invasive surgeries have enhanced market demand. The awareness of advanced cardiovascular interventions and the growing number of surgical procedures worldwide have greatly contributed to the expansion of the market. In addition, the investment in R&D by major players to enhance cannula design and functionality is a key driver of innovation, which is further fueling market growth. The demand for ECMO procedures, especially during critical care situations like COVID-19, has also positively influenced the market trajectory.
Restraints
Despite its growth, the Global Arterial Cannula Market is facing several challenges. High costs associated with cardiovascular surgeries and arterial cannula devices prevent its widespread adoption, especially in developing countries where healthcare budgets are limited. Regulatory hurdles and stringent approval processes for medical devices create complexity and delay product launches. Complications associated with arterial cannulas, such as thrombosis, infection, or vessel damage, pose a significant challenge for manufacturers and healthcare providers. The availability of other treatments and insufficiently qualified professionals for carrying out surgeries can limit market growth in this region.
Opportunity
The Global Arterial Cannula Market is highly promising and offers huge opportunities, primarily in emerging economies. Huge investments in healthcare infrastructure and an increasing awareness of advanced medical treatments in Asia-Pacific and Latin America will drive the growth rate. Innovation in cannula design, including anti-thrombogenic coatings and advanced biomaterials, provides avenues for enhanced patient safety and clinical outcomes. Acceleration is seen in the collaboration between research institutions and medical device companies to further develop next-generation products. Additionally, the increasing acceptance of ECMO in neonates and adults creates new market opportunities for players to expand their product offerings.
Trend
Smart technologies have been one of the major trends in the Global Arterial Cannula Market. Sensors inside cannulas that monitor blood flow and can detect complications in real time are being increasingly adopted. Customized cannulas are also becoming the norm, where technology allows for the individual patient anatomy to be utilized. This is due to the development of 3D printing technology. The market is witnessing increased focus on sustainability, with manufacturers exploring eco-friendly materials and production processes. Additionally, there is a growing emphasis on minimally invasive cannulation techniques, driven by patient demand for faster recovery times and reduced post-operative complications.
Approved Products Pipeline/Reg/Pre-Reg Products
Medtronic Bio-Medicus NextGen Cannula
Terumo Cardiovascular Soft-Flow Arterial Cannula
Edwards Lifesciences Thin-Flex Cannula
LivaNova Bi-Flow Arterial Cannula
Getinge Avalon Elite Bi-Caval Catheter
B. Braun ArtiCure Cannula Series
Key Target Audience
Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Medical Device Distributors
Research and Academic Institutes
Cardiovascular Surgeons
Frequently Asked Questions (FAQ's)
The market size is approximately USD 1.2 billion as of 2024.
Increasing prevalence of cardiovascular diseases and advancements in minimally invasive surgical procedures.
North America and Europe are dominant, with Asia-Pacific emerging as a high-growth region.
High costs, regulatory hurdles, and complications related to cannula use.
Major companies include Medtronic, Terumo Corporation, and Edwards Lifesciences.
Introduction
1.1 Report Description
1.2 Research Methodology
1.2.1 Data Mining
1.2.2 Market Modeling and Forecasting
1.2.3 Data Validation
1.2.4 Industry Analysis
Market Dashboard
Market Overview
3.1 Market Definition and Scope
3.2 Market Segmentation
3.2.1 By Treatment Types
3.2.1.1 Chemotherapy
Induction Phase
Consolidation Phase
Maintenance Phase
3.2.1.2 Targeted Therapies
Tyrosine Kinase Inhibitors
Antibody-Drug Conjugates
Others
3.2.1.3 Immunotherapies
CAR-T Therapy
Monoclonal Antibodies
3.2.2 By Patient Demographics
3.2.2.1 Children
Infants
Toddlers and Young Children
3.2.2.2 Adults
Young Adults
Seniors
3.2.3 By Distribution Channels
3.2.3.1 Hospital Pharmacies
Tertiary Care Centers
Pediatric Oncology Units
3.2.3.2 Retail Pharmacies
Local Pharmacies
Chain Pharmacies
3.2.3.3 Online Pharmacies
3.2.4 By Therapeutic Applications
3.2.4.1 First-Line Treatment
Chemotherapy-Only Regimens
Targeted Therapies
3.2.4.2 Relapse or Refractory ALL
CAR-T Therapies
Experimental Treatments
Global Arterial Cannula Market by Region
4.1 North America
United States
Canada
4.2 Europe
Germany
France
United Kingdom
Rest of Europe
4.3 Asia Pacific
China
Japan
India
Southeast Asia
Rest of Asia Pacific
4.4 Latin America
Brazil
Rest of Latin America
4.5 Middle East & Africa (MEA)
GCC
North Africa
South Africa
Rest of MEA
Market Dynamics
5.1 Drivers
5.2 Restraints
5.3 Opportunities
5.4 Challenges
Competitive Landscape
6.1 Company Profiles
6.1.1 Amgen Inc. (United States)
6.1.2 Novartis AG (Switzerland)
6.1.3 Pfizer Inc. (United States)
6.1.4 Gilead Sciences (United States)
6.1.5 Kite Pharma (United States)
6.1.6 Takeda Pharmaceutical Company (Japan)
6.1.7 Bristol-Myers Squibb (United States)
6.1.8 Jazz Pharmaceuticals (Ireland)
6.1.9 AbbVie Inc. (United States)
6.1.10 Sanofi (France)
6.1.11 Autolus Therapeutics (United Kingdom)
6.1.12 Cellectis (France)
6.1.13 Allogene Therapeutics (United States)
6.1.14 Celgene Corporation (United States)
6.1.15 Eli Lilly and Company (United States)
List of Tables and Figures
Table 1: Market Size by Region (2024-2030)
Table 2: Key Market Players and Their Offerings
Figure 1: Market Segmentation Overview
Figure 2: Growth Rate by Treatment Type
Figure 3: Distribution Channel Analysis
Research Methodology
The process of market research at Ultra Market Research is an iterative in application and usually follows following path. Information from secondary used to build data models, then results from data models are validated from primary participants. Then cycle repeats where, according to inputs from primary participants, additional secondary research is done, and new Information is again incorporated into data model. The process continues till desired level of Information is not generated
To calculate the market size, the report considers the revenue generated from the sales of Ultra Market Research providers. The revenue generated from the sales of Ultra Market Research has been calculated through primary and secondary research. The report also presents the key players operating in the Ultra Market Research market across the globe identified through secondary research and a corresponding detailed analysis of the top vendors in the market. The market size calculation also includes distribution channel segmentation determined using secondary sources and verified through primary sources.
Secondary Research
The secondary research source that are typically referred to include, but are not limited to:
Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
Internal and external proprietary databases, relevant patent and regulatory databases
National government documents, statistical databases and market reports
News articles, press releases and web-casts specific to the companies operating in the market
The source for secondary research includes but is not limited to: Factiva, Hoovers and Statista
Inner Circle Represents – Stage of Research Process
Middle Circle Represents – Source of Information
Outer Circle Represents – Information Derived from that source
Primary Research We conduct primary interviews on an ongoing basis with industry participants and commentators in order to validate data and analysis. A typical research interview fulfills the following functions:
It provides first-hand Information on the market size, market trends, growth trends, competitive landscape, future outlook etc.
Helps in validating and strengthening the secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves E-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies
The participants who typically take part in such a process include, but are not limited to:
Industry participants: CEOs, VPs, marketing/ distribution channel managers, market intelligence managers and national sales managers
Purchasing managers, technical personnel, distributors and resellers
Outside experts: Investment bankers, valuation experts, research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry distribution channels
Models Where no hard data is available, we use modeling and estimates in order to produce comprehensive data sets. A rigorous methodology is adopted in which the available hard data is cross referenced with the following data distribution channels to produce estimates:
Demographic data: Population split by segment
Macro-economic indicators: GDP, etc.
Industry indicators: Expenditure, distribution channel stage & infrastructure, sector growth and facilities.
Data is then cross checked by the expert panel.
2..1 Company Share Analysis Model
Company share analysis is used to derive the size of Global market. As well as study of revenues of companies for last three to five years also provide the base for forecasting the market size and its growth rate. This model is built in following steps: 2..2 Revenue Based Modeling
Revenue based models can be built in two ways – Top-Down or Bottom-Up irrespective of industry. Market size estimated from company share analysis acts as a validation point for bottom-up approach where as it acts as starting point for top-down approach.
2.1 Research Limitations Inflation is not a part of pricing in this report. Prices of Arterial Cannula Market and its derivatives vary in each region and hence similar revenue ratio does not follow for each individual region. The same price for each distribution channel has been taken into account while estimating and forecasting market revenue Globally. Regional average price has been considered while breaking down this market by application in each region. This report provides market size of Arterial Cannula Market for the past year and forecasts for the next six years. Arterial Cannula Market size is given in terms of revenue. Market revenue is defined in USD Million. Market numbers are given on the basis of different Arterial Cannula Market categories. Market size and forecasts for each major application is provided in the context of Global market. The numbers provided in this report are derived on the basis of demand for Arterial Cannula Market from different application industries in different regions.
